The mesenteric and antimesenteric location of colorectal cancer: The relationship with lymph nodes metastases

Surgeon

Volumn 2, Issue 4, 2004, Pages 214-220

  Benevento, A ^a   Boni, L ^a   Dionigi, G ^a   Carcano, G ^a   Capella, C ^a   Capriata, G ^b   Casula, G ^c   Dettori, G ^d   Dionigi, R ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b VALDUCE HOSPITAL   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

Author keywords

Antimesenteric; Colorectal cancer; Lymph node metastases; Mesenteric; Prognostic factors; Vascular anatomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CHI SQUARE TEST; COLORECTAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHESIS; LINEAR SYSTEM; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENTERY TUMOR; MICROSATELLITE INSTABILITY; PROGNOSIS; SURVIVAL RATE;

EID: 4344697843     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(04)80003-9     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Hannisdall E, Thorsen G. Regression analyses of prognostic factors in colorectal cancer. J Surg Oncol 1988; 37: 109-112.
3. Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000 Apr;29:197-207.
4. Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 1994;86:997-1006.
5. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL.. Pathologic determinants of survival associated with colon or rectal cancer with lymph node metastases: a multivariate analysis of 579 patients. Cancer. 1994; 73: 2076-82.
6. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR et al. Prognostic factors in colorectal cancer. Arch Pathol Lab Med. 2000; 124: 979-94.
7. Crucitti F, Sofo L, Doglietto GB, Bellantone R, Ratto C, Bossola M, Crucitti A. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol suppl. 1991; 2: 76-82.
8. Hannisdal E, Thorsen G. Regression analyses of prognostic factors in colorectal cancer. J Surg Oncol 1988; 37: 109-112.
9. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr, Melton LJ 3rd. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60:2318-24.
10. Minsky B, Mies C. The clinical significance of vascular invasion in colorectal cancer. Dis Colon Rectum 1989;32:794-803.
11. Knudsen JB, Nilsson T, Sprechler M, Johansen A, Christensen N. Venous and nerve invasion as prognostic factors in post-operative survival of patients with resectable cancer of the rectum. Dis Colon Rectum. 1983; 26: 613-17.
12. Fielding LP, Phillips RKS, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986;2:904-7.
13. Svennevig JL, Lunde OC, Holter J, Bjorgsvik D. Lymphoid infiltration and prognosis in colorectal carcinoma. Br J Cancer. 1984; 49: 375-77.
14. Jass JR. The pathological grading and staging of rectal cancer. Scand J Gastroenterol Suppl 1988;149:21-38.
15. Saccani Jotti G, Fontanesi M, Orsi N, Sarli L, Pietra N, Peracchia A, et al. DNA content in human colon cancer and non-neoplastic adjacent mucosa. Int J Biol Markers 1995;10:11-16.
16. Lanza G, Matteuzzi M, Gafa R, Orvieto E, Maestri I, Santini A, del Senno L. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 1998;79:390-95.
17. Ogunbiyi OA, Goodfellow PJ, Herfarth K, Gagliardi G, Swanson PE, Birnbaum EH, et al. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 1998;16:427-33.
18. Dukes CE. The classification of the cancer of the rectum. J Pathol Bacteriol. 1940; 50: 527.
19. Astler VB, Coller FA. Prognostic significance of direct extension of carcinoma of the colon and rectum, Ann Surg 1954; 139: 846-52.
20. Grinnell RS. The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 1939; 109: 500.
21. Gilchrist R, David D. Lymphatic spread of carcinoma of the rectum. Ann Surg 1948;38:621.
22. Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg 1995;82:1297-99.
23. De Vita VT, Hellman S, Rosemberg SA. Cancer Principles & Practice of Oncology. 6th edn. Philadelphia: Lipincott Williams & Wilkins. 2001:1216-71.
24. Hossler FE, West RF. Venous valve anatomy and morphometry: studies on the duckling using vascular corrosion casting. Am J Anat 1988 Apr;181:425-32.
25. Goldstein N, Hart J. Histologic features associated with lymph node metastasis in stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant therapy or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999;111:51-58.
26. Mainprize KS, Kulacoglu H, Hewavisinthe J, Savage A, Mortensen N, Warren BF. How many lymph nodes to stage colorectal carcinoma? J Clin Pathol 1998;51:165-66.
27. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastasis of any clinical significance in Dukes stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244-49.
28. Ragnhammar P, Hafstrom L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001;40:282-308.
29. Ooi BS, Tjandra JJ, Green MD. Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview. Dis Colon Rectum 1999 Mar;42:403-18.
30. Schmoll HJ. Adjuvant chemotherapy in rectal cancer. Chirurg 1994 Jul;65: 576-84.